This document discusses CML management in Bolivia. It notes that Bolivia has a population of 10 million but only 35 hematologists, most located in one city. The health system has public, private, and social security components but no insurance covers CML medications. Around 200 CML patients receive imatinib from charitable programs. Diagnosis relies on PCR but not cytogenetics. The document describes a rare case of CML in an 8-year old girl who achieved a hematological response on imatinib. It emphasizes the need to improve access to diagnostics and treatments for CML patients in Bolivia.